Ronald Kapusta Biography and Net Worth



Johnson & Johnson said its controller and chief accounting officer, Ronald Kapusta, is retiring as of Dec. 27.

Robert Decker Jr. will replace Kapusta in the roles, the healthcare giant said in an Oct. 7 filing.

Decker joined the New Brunswick, N.J.-based company in 1993 and was appointed assistant corporate controller in August 2017.

What is Ronald A. Kapusta's net worth?

The estimated net worth of Ronald A. Kapusta is at least $2.23 million as of December 13th, 2018. Mr. Kapusta owns 13,641 shares of Johnson & Johnson stock worth more than $2,232,077 as of March 28th. This net worth evaluation does not reflect any other investments that Mr. Kapusta may own. Learn More about Ronald A. Kapusta's net worth.

How do I contact Ronald A. Kapusta?

The corporate mailing address for Mr. Kapusta and other Johnson & Johnson executives is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. Johnson & Johnson can also be reached via phone at (732) 524-0400 and via email at investor-relations@its.jnj.com. Learn More on Ronald A. Kapusta's contact information.

Has Ronald A. Kapusta been buying or selling shares of Johnson & Johnson?

Ronald A. Kapusta has not been actively trading shares of Johnson & Johnson within the last three months. Most recently, Ronald A. Kapusta sold 3,643 shares of the business's stock in a transaction on Thursday, December 13th. The shares were sold at an average price of $147.31, for a transaction totalling $536,650.33. Following the completion of the sale, the chief accounting officer now directly owns 13,641 shares of the company's stock, valued at $2,009,455.71. Learn More on Ronald A. Kapusta's trading history.

Who are Johnson & Johnson's active insiders?

Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Chairman), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Timothy Schmid (EVP, Worldwide Chairman, MedTech), Michael Sneed (COO), Paulus Stoffels (VP), James Swanson (EVP), Jennifer Taubert (EVP), Mark Weinberger (Director), Kathryn Wengel (EVP), Joseph Wolk (CFO), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.

Are insiders buying or selling shares of Johnson & Johnson?

During the last year, Johnson & Johnson insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $147,220.00. During the last year, insiders at the sold shares 3 times. They sold a total of 13,037 shares worth more than $2,154,035.67. The most recent insider tranaction occured on February, 25th when VP Robert J Decker sold 6,999 shares worth more than $1,160,994.12. Insiders at Johnson & Johnson own 0.2% of the company. Learn More about insider trades at Johnson & Johnson.

Information on this page was last updated on 2/25/2025.

Ronald A. Kapusta Insider Trading History at Johnson & Johnson

See Full Table

Ronald A. Kapusta Buying and Selling Activity at Johnson & Johnson

This chart shows Ronald A Kapusta's buying and selling at Johnson & Johnson by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1$0Total Insider BuyingTotal Insider Selling

Johnson & Johnson Company Overview

Johnson & Johnson logo
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Read More

Today's Range

Now: $163.63
Low: $162.91
High: $164.52

50 Day Range

MA: $158.68
Low: $145.39
High: $167.57

2 Week Range

Now: $163.63
Low: $140.68
High: $169.99

Volume

5,760,266 shs

Average Volume

7,625,268 shs

Market Capitalization

$394.32 billion

P/E Ratio

24.61

Dividend Yield

3.08%

Beta

0.47